Although further investigations are required to elucidate the molecular mechanisms of CETP C-629A polymorphism underlying CHD, future studies on the relationship between CETP genetic defects and CHD susceptibility need to focus on gene-to-environment interactions, especially on the impact of the -629C allele on circulating lipid changes. This evidence concerns the gene CETP and coronary artery disorder.